Literature DB >> 11819250

Hepatic adenylate energy charge levels in patients with hepatoma after hepatic artery embolization.

Li Li, Lu-Nan Yan, Xiao-Li Chen, Wu-Sheng Lu, Xiao-Dong Xie, Yan-Tao Wu.   

Abstract

AIM:To evaluate hepatic energy charge levels of the patients with hepatoma after hepatic artery embolization and its relation to postoperative complications.
METHODS: Sixty-nine patients with hepatoma were continuously measured for their arterial blood ketone body ratio (AKBR) and compared with their postoperative clinical course or conventional liver function test after various hepatic artery embolization.
RESULTS: AKBR in high radiation dose or jaundice group drastically decreased at 1-3 days and recovered slowly. Patients were classified into three groups according to the value of AKBR: group A (35 cases), AKBR remained higher than 0.7; group B (31 cases), AKBR had transiently dropped to 0.4-0.7 and then increased to preoperative value; and group C (3 cases), AKBR decreased steadily to below 0.4.The occurrence rate of various complications were 5.7%, 32.3% and 100% in the three groups, respectively (P < 0.005).
CONCLUSION: The AKBR which reflects hepatic mitochondria redox state is more reliable as a direct indicator to assess hepatic tolerance for embolization than routine liver function test.

Entities:  

Year:  1998        PMID: 11819250      PMCID: PMC4688628          DOI: 10.3748/wjg.v4.i2.109

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  4 in total

1.  Linear correlation between acetoacetate/beta-hydroxybutyrate in arterial blood and oxidized flavoprotein/reduced pyridine nucleotide in freeze-trapped human liver tissue.

Authors:  K Ozawa; B Chance; A Tanaka; S Iwata; T Kitai; I Ikai
Journal:  Biochim Biophys Acta       Date:  1992-04-14

2.  Transcatheter hepatic arterial drug infusion therapy for hepatocellular carcinoma. Effect on the arterial ketone body ratio.

Authors:  K Kajimura; F Moriyasu; H Someda; M Okuma; K Mori; K Ozawa
Journal:  Scand J Gastroenterol       Date:  1993-06       Impact factor: 2.423

3.  Diurnal fluctuations of arterial ketone body ratio in normal subjects and patients with liver dysfunction.

Authors:  S Iwata; K Ozawa; Y Shimahara; K Mori; N Kobayashi; K Kumada; Y Yamaoka
Journal:  Gastroenterology       Date:  1991-05       Impact factor: 22.682

4.  Five-year survival after transcatheter chemoembolization for hepatocellular carcinoma.

Authors:  H Nakamura; T Mitani; T Murakami; T Hashimoto; K Tsuda; K Nakanishi; T Ishida; K Tomoda; S Hori; T Kozuka
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.